Positron Corp. (OTCMKTS:POSC) Sees Significant Growth in Short Interest

Positron Corp. (OTCMKTS:POSC) was the recipient of a large growth in short interest during the month of October. As of October 30th, there was short interest totaling 1,278 shares, a growth of 387.8% from the October 15th total of 262 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 11,347 shares, the days-to-cover ratio is currently 0.1 days.

Positron Stock Down 5.6%

Shares of OTCMKTS POSC traded down $0.10 during trading hours on Thursday, hitting $1.70. 3,202 shares of the stock were exchanged, compared to its average volume of 41,160. Positron has a 12 month low of $1.27 and a 12 month high of $2.74. The firm has a fifty day moving average price of $1.74 and a 200-day moving average price of $1.82. The company has a market cap of $56.26 million, a PE ratio of -5.31 and a beta of 0.67.

Positron (OTCMKTS:POSC) last announced its earnings results on Friday, August 14th. The company reported ($0.03) earnings per share for the quarter. Positron had a negative net margin of 2,279.55% and a negative return on equity of 2,415.88%. The firm had revenue of $0.11 million during the quarter.

About Positron

Positron Corporation (OTCMKTS: POSC) is a medical technology company focused on positron emission tomography (PET), a nuclear-imaging technique used to support the diagnosis and management of disease. Its activities include the development, manufacture and distribution of PET imaging systems and related products for healthcare providers. The company has emphasized cardiac PET imaging, an application that can help physicians evaluate heart function and blood flow. Positron’s product offerings have included dedicated PET equipment, such as the Attrius PET system, along with related imaging and radiopharmaceutical solutions.